PVI
Pura Vida Investments Portfolio holdings
AUM
$16.6M
This Quarter Return
+8.42%
1 Year Return
-3.82%
3 Year Return
-0.02%
5 Year Return
+29.84%
10 Year Return
+256.58%
AUM
$189M
AUM Growth
+$189M
(+20%)
Cap. Flow
+$20.1M
Cap. Flow
% of AUM
10.59%
Top 10 Holdings %
Top 10 Hldgs %
34.3%
Holding
90
New
16
Increased
24
Reduced
13
Closed
14
Top Buys
| 1 |
Medtronic
MDT
|
$6.94M |
| 2 |
Centene
CNC
|
$5.32M |
| 3 |
Stryker
SYK
|
$4.79M |
| 4 |
AET
Aetna Inc
AET
|
$4.58M |
| 5 |
GSK
GSK
|
$4.3M |
Top Sells
| 1 |
AGN
Allergan plc
AGN
|
$7.99M |
| 2 |
AbbVie
ABBV
|
$5.99M |
| 3 |
Agilent Technologies
A
|
$3.59M |
| 4 |
Pfizer
PFE
|
$2.9M |
| 5 |
ELGX
Endologix Inc
ELGX
|
$2.88M |
Sector Composition
| 1 | Healthcare | 77.98% |
| 2 | Financials | 5% |
| 3 | Industrials | 2.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AET
1
DELISTED
Aetna Inc
AET
| $9.47M | 4.02% | 77,500 +37,500 | +94% | +$4.58M |
|
|
2
Centene
CNC
$14.3B
| $7.49M | 3.19% | 105,000 +74,476 | +244% | +$5.32M |
|
|
3
Medtronic
MDT
$119B
| $6.94M | 2.95% | +80,000 | New | +$6.94M |
|
4
Baxter International
BAX
$12.7B
| $6.66M | 2.83% | 147,305 -7,695 | -5% | -$348K |
|
5
Zimmer Biomet
ZBH
$21B
| $6.62M | 2.81% | 55,000 +19,200 | +54% | +$2.31M |
|
6
Bristol-Myers Squibb
BMY
$96B
| $6.34M | 2.7% | 86,250 +10,750 | +14% | +$791K |
|
|
SHPG
7
DELISTED
Shire pic
SHPG
| $5.52M | 2.35% | 30,000 +6,750 | +29% | +$1.24M |
|
8
Universal Health Services
UHS
$11.6B
| $5.36M | 2.28% | 40,000 -10,000 | -20% | -$1.34M |
|
|
EVHC
9
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $5.33M | 2.26% | 210,000 +35,000 | +20% | +$888K |
|
|
ALXN
10
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $5.22M | 2.22% | 44,670 +8,670 | +24% | +$1.01M |
|
11
McKesson
MCK
$85.4B
| $5.13M | 2.18% | 27,500 +9,000 | +49% | +$1.68M |
|
|
12
Stryker
SYK
$150B
| $4.79M | 2.04% | +40,000 | New | +$4.79M |
|
13
Eli Lilly
LLY
$657B
| $4.41M | 1.87% | 56,000 +14,000 | +33% | +$1.1M |
|
14
Insulet
PODD
$23.9B
| $4.4M | 1.87% | 145,500 -29,500 | -17% | -$892K |
|
|
NXTM
15
DELISTED
NxStage Medical Inc.
NXTM
| $4.34M | 1.84% | 200,000 -40,157 | -17% | -$871K |
|
16
Boston Scientific
BSX
$156B
| $4.32M | 1.84% | 185,000 -115,000 | -38% | -$2.69M |
|
|
17
GSK
GSK
$79.9B
| $4.3M | 1.83% | +99,125 | New | +$4.3M |
|
18
Owens & Minor
OMI
$378M
| $4.16M | 1.77% | 111,400 +6,400 | +6% | +$239K |
|
19
Amgen
AMGN
$155B
| $4.15M | 1.76% | 27,250 +1,675 | +7% | +$255K |
|
|
20
Pfizer
PFE
$141B
| $4.14M | 1.76% | 117,675 -82,325 | -41% | -$2.9M |
|
|
ATHN
21
DELISTED
Athenahealth, Inc.
ATHN
| $4.14M | 1.76% | 30,000 | – | – |
|
|
CELG
22
DELISTED
Celgene Corp
CELG
| $4.13M | 1.76% | 41,875 +22,750 | +119% | +$2.24M |
|
23
Abbott
ABT
$231B
| $3.93M | 1.67% | 100,000 -25,000 | -20% | -$983K |
|
|
WMGI
24
DELISTED
Wright Medical Group Inc
WMGI
| $3.91M | 1.66% | 225,000 +13,078 | +6% | +$227K |
|
25
CVS Health
CVS
$92.8B
| $3.83M | 1.63% | +40,000 | New | +$3.83M |
|